'Proc asco' presentation slideshows

1 in 4 Deaths CANCER

Current Approaches in Metastatic Breast Cancer Edgardo Rivera, MD Chief, Breast Medical Oncology Section The Methodist Hospital/Weill Cornell University Houston, TX. 1 in 4 Deaths CANCER. Leading cause of death among women aged 40 to 79 years

949 views • 55 slides

A Systematic Analysis of VTE Prophylaxis in the Setting of Cancer

597 views • 47 slides

YEAR IN REVIEW 2012: GU

366 views • 23 slides

UNANSWERED QUESTIONS IN UPFRONT THERAPY CHEMOTHERAPY ISSUES: WEEKLY DOSING

330 views • 20 slides

Burger RA et al. Proc ASCO 2010;Abstract LBA1.

Phase III Trial of Bevacizumab in the Primary Treatment of Advanced Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer: A Gynecologic Oncology Group (GOG) Study. Burger RA et al. Proc ASCO 2010;Abstract LBA1. Introduction.

379 views • 16 slides

Castration-Resistant Metastatic Prostate Cancer: Novel Therapeutics

Castration-Resistant Metastatic Prostate Cancer: Novel Therapeutics. Robert Dreicer, M.D., M.S., FACP Chairman Department of Solid Tumor Oncology Taussig Cancer Institute Cleveland Clinic Professor of Medicine Cleveland Clinic Lerner College of Medicine. Clinical States In Prostate Cancer.

357 views • 15 slides

Seymour JF et al. 1 Proc ICML 2013;Abstract 057. 2 Proc ASCO 2013;Abstract 7018.

Updated Results of a Phase I First-in-Human Study of the BCL-2 Inhibitor ABT-199 (GDC-0199) in Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) 1,2. Seymour JF et al. 1 Proc ICML 2013;Abstract 057. 2 Proc ASCO 2013;Abstract 7018. Background.

312 views • 10 slides

Temel JS et al. Proc ASCO 2010;Abstract 7509.

Effect of Early Palliative Care (PC) on Quality of Life (QOL), Aggressive Care at the End-of-Life (EOL), and Survival in Stage IV NSCLC Patients: Results of a Phase III Randomized Trial. Temel JS et al. Proc ASCO 2010;Abstract 7509. Trial Schema.

210 views • 8 slides